TB-500 + GHK-Cu
aka tb500ghkcu
Healing & Recovery
Mechanism
Grey-market vendor blend combining TB-500 (a synthetic heptapeptide fragment of Thymosin Beta-4, not full-length Tβ4) and GHK-Cu (a copper tripeptide). This blend is not clinically validated; evidence is extrapolated from individual-component research, and no human trials of the combination exist.
Identification
| Typical dose | TB-500: 2–5 mg 2x/week subcutaneous; GHK-Cu: 1–2 mg/day subcutaneous (research use only) |
|---|---|
| Half-life | TB-500: ~2–3 days; GHK-Cu: ~30–60 minutes |
Vendors selling TB-500 + GHK-Cu
No vendor listings on file yet.
Research
Injuries, Injections, and Internet Forums: A Qualitative Study of Reddit User Perspectives on Peptide Therapy After Orthopaedic Surgery
Rosenberg AE, Taylor B, Rasquinha RD, Khan H, Quinn M, Marcaccio S, Lemme N. · Sports health (2026) ·
source →